FDA approves Botox to treat specific form of urinary incontinence

Posted by Food and Drug Administration--Press Releases on Wednesday Aug 24, 2011 Under News

The U.S. Food and Drug Administration today approved Botox (onabotulinumtoxinA) injection to treat urinary incontinence in people with neurologic conditions such as spinal cord injury and multiple sclerosis who have overactivity of the bladder.

Be Sociable, Share!

Comments are closed.